Condition: Lymphoma, B-Cell · Lymphoma · Large-cell Lymphoma · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
This description comes directly from the study's public registry record.
Kelly McConnell, PhD · 646-888-0026 · McConneK@mskcc.org
Revecca Saracino, PhD · 646-888-0263 · jamesr@mskcc.org
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Cancer Center (All protocol activities) | New York, New York, United States | Recruiting |
| NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) | New York, New York, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05940272